US 12,337,024

Application 17/635,441 · Granted Jun 24, 2025

Larazotide formulations

Estimated expiration

December 25, 2040

14y 38d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Aug 14, 2020
+ 20 years
Aug 14, 2040
PTA +133d
Dec 25, 2040
No TD
—
Final
Dec 25, 2040

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
February 15, 2022
Earliest effective filing
August 14, 2020
Issue date
June 24, 2025
PTA
+133 days
Base expiry (before PTA)
August 14, 2040

August 14, 2020 + 20 years = August 14, 2040 + 133 PTA days = December 25, 2040

  • National stage entry of application PCTUS2020046272, filed Aug 14, 2020
  • PRO63/009,768 — Provisional — not used for base term
  • PRO62/888,052 — Provisional — not used for base term
  • PRO63/009,768 — Provisional — not used for base term
  • PRO62/888,052 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/635,441 · US 12,337,024

PatentReply compiles the prosecution history behind US 12,337,024: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12337024

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.